Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer
- PMID: 30997243
- PMCID: PMC6424718
- DOI: 10.21037/jtd.2018.11.44
Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer
Conflict of interest statement
Conflicts of Interest: The author has no conflicts of interest to declare.
Comment in
-
Role of skeletal muscle on chest computed tomography for risk stratification of lung cancer patients.J Thorac Dis. 2019 Mar;11(Suppl 3):S483-S484. doi: 10.21037/jtd.2019.01.73. J Thorac Dis. 2019. PMID: 30997904 Free PMC article. No abstract available.
Comment on
-
Thoracic Skeletal Muscle Is Associated With Adverse Outcomes After Lobectomy for Lung Cancer.Ann Thorac Surg. 2018 May;105(5):1507-1515. doi: 10.1016/j.athoracsur.2018.01.013. Epub 2018 Feb 3. Ann Thorac Surg. 2018. PMID: 29408306
References
Publication types
LinkOut - more resources
Full Text Sources